[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ad Scientiam - Product Pipeline Analysis, 2020 Update

January 2021 | 38 pages | ID: A4DAED4E9067EN
GlobalData

US$ 750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare professionals and pharmaceutical companies. The company’s solution finds application in the areas of Parkinson disease, Asthma, Atopic Dermatisi, Insomnia, Multiple Sclerosis, Oncology and Alzheimer's disease among others. It also operates an office in the US. Ad Scientiam is headquartered in Paris, Ile de France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ad Scientiam
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Ad Scientiam Company Overview
Ad Scientiam Company Snapshot
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam – Pipeline Analysis Overview
Ad Scientiam - Key Facts
Ad Scientiam - Major Products and Services
Ad Scientiam Pipeline Products by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Pipeline Products Overview
Actisleep
Actisleep Product Overview
CARDICARE
CARDICARE Product Overview
CARDICARE Clinical Trial
Mobile Application - Alzheimer’s
Mobile Application - Alzheimer’s Product Overview
Mobile Application - Asthma
Mobile Application - Asthma Product Overview
Mobile Application - Insomnia
Mobile Application - Insomnia Product Overview
Mobile Application - Major Depressive Disorder
Mobile Application - Major Depressive Disorder Product Overview
Mobile Application - Major Depressive Disorder Clinical Trial
Mobile Application - Oncology
Mobile Application - Oncology Product Overview
Mobile Application - Parkinson’s
Mobile Application - Parkinson’s Product Overview
Mobile Application - Rheumatoid Arthritis
Mobile Application - Rheumatoid Arthritis Product Overview
Mobile Application - Schizophrenia
Mobile Application - Schizophrenia Product Overview
MSCopilot Mobile App
MSCopilot Mobile App Product Overview
Ad Scientiam - Key Competitors
Ad Scientiam - Key Employees
Ad Scientiam - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Ad Scientiam, Recent Developments
Oct 28, 2019: Ad Scientiam tracks valuable digital biomarkers for clinical research
Jan 29, 2019: Ad Scientiam selected for Pfizer Acceleration Program
Nov 14, 2018: Ad Scientiam announces clinical validation of its MSCopilot solution
Nov 14, 2018: Ad Scientiam, a french startup hosted at the Brain & Spine Institute (paris), announces clinical validation of its MSCopilot solution
Jul 18, 2018: MyHBP, application dedicated to the monitoring of benign prostatic hypertrophy
Jul 18, 2018: TLM : new version of MSCopilot
Jul 17, 2018: Ad Scientiam selected for EIT Health GoGlobal Canada Programme
Jun 08, 2018: Altran accompanies Ad Scientiam on the European compliance of MSCopilot
Jun 01, 2018: The 16 Health start-ups selected by Product Market Fit
May 30, 2018: MSCopilot is evolving for World MS Day
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam Pipeline Products by Equipment Type
Ad Scientiam Pipeline Products by Indication
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam, Key Facts
Ad Scientiam, Major Products and Services
Ad Scientiam Number of Pipeline Products by Development Stage
Ad Scientiam Pipeline Products Summary by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Ongoing Clinical Trials Summary
Actisleep - Product Status
Actisleep - Product Description
CARDICARE - Product Status
CARDICARE - Product Description
CARDICARE - Impact of a Digital Solution (CardiCare) on Cardiorespiratory Fitness Improvement in Patients Discharged from a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome
Mobile Application - Alzheimer’s - Product Status
Mobile Application - Alzheimer’s - Product Description
Mobile Application - Asthma - Product Status
Mobile Application - Asthma - Product Description
Mobile Application - Insomnia - Product Status
Mobile Application - Insomnia - Product Description
Mobile Application - Major Depressive Disorder - Product Status
Mobile Application - Major Depressive Disorder - Product Description
Mobile Application - Major Depressive Disorder - Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
Mobile Application - Oncology - Product Status
Mobile Application - Oncology - Product Description
Mobile Application - Parkinson’s - Product Status
Mobile Application - Parkinson’s - Product Description
Mobile Application - Rheumatoid Arthritis - Product Status
Mobile Application - Rheumatoid Arthritis - Product Description
Mobile Application - Schizophrenia - Product Status
Mobile Application - Schizophrenia - Product Description
MSCopilot Mobile App - Product Status
MSCopilot Mobile App - Product Description
Ad Scientiam, Key Employees
Ad Scientiam, Other Locations
Glossary

LIST OF FIGURES

Ad Scientiam Pipeline Products by Equipment Type
Ad Scientiam Pipeline Products by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

Bionext SA
Biocitech SAS
Altrabio SAS


More Publications